The 16th recipients of the Rohto Women's Health Science Research Award, a research grant
awarded by Rohto Pharmaceutical to researchers with the aim of advancing obstetrics and gynecology research, have been announced.
May 26, 2025
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City; President: Masashi Sugimoto) has announced the 16th recipient of the Rohto Women's Health Research Award which is given to obstetrics and gynecology researchers. A commemorative lecture was held at the 77th Japan Society of Obstetrics and Gynecology Academic Conference (May 23-25, 2025, Okayama City) co-hosted by the company.
About Rohto Women's Health Research Award
It developed from the Women's Health Science Research Group, which was established in 2009, and was established by Rohto Pharmaceutical in 2019.
The award is given to researchers at Japanese universities and equivalent research institutions who have made outstanding achievements in obstetrics and gynecology research, with the aim of promoting research on maternal health and infertility treatment, as well as research on women's healthy longevity in the era of the 100th anniversary of their birth, thereby contributing to the development and improvement of obstetrics and gynecology research in Japan.
After a rigorous and fair review by a selection committee consisting of seven academic experts in women's health research, three researchers who are conducting outstanding research are awarded a plaque and a prize (a total of 5 million yen, with 1 to 3 million yen per person).
This year, the following three researchers will be awarded the prize, and the following additional prizes will be presented by Rohto Pharmaceutical.
16th Award Winner
| full name |
Affiliation |
Presentation title |
Second Prize |
| Mr. Manabu Ikenoue |
Keio University |
Fetal Origins of Obesity - A New Ultrasound Approach to Assessing Fetal Growth |
2 million yen |
| Ms. Tomoko Osuga |
Aichi Medical University |
Development of translational research that contributes to improving ART outcomes from early diagnosis of POI |
1.7 million yen |
| Mr. Hiromitsu Shirasawa |
Akita University Hospital |
Multifaceted approach to ART/add-ons taking into account social insurance and medical systems |
1.3 million yen |